4 results match your criteria: "Translational Gastroenterology Unit and NIHR Oxford Biomedical Research Centre[Affiliation]"
Surg Obes Relat Dis
June 2024
Translational Gastroenterology Unit and NIHR Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom. Electronic address:
Background: Protein glycosylation is an enzymatic process known to reflect an individual's physiologic state and changes thereof. The impact of metabolic interventions on plasma protein N-glycosylation has only been sparsely investigated.
Objective: To examine alterations in plasma protein N-glycosylation following changes in caloric intake and bariatric surgery.
Int J Obes (Lond)
July 2021
Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
Background: Obesity, a major global health problem, is associated with increased cardiometabolic morbidity and mortality. Protein glycosylation is a frequent posttranslational modification, highly responsive to inflammation and ageing. The prospect of biological age reduction, by changing glycosylation patterns through metabolic intervention, opens many possibilities.
View Article and Find Full Text PDFFrontline Gastroenterol
October 2019
Hepatology, Translational Gastroenterology Unit and NIHR Oxford Biomedical Research Centre, Oxford, UK.
Objective: Immune checkpoint inhibitors like anti-programmed cell death protein 1 (PD-1) drugs Nivolumab and Pembrolizumab and anti-cytotoxic T-lymphocyte associated (CTLA-4) drug Ipilimumab have become standard of care in many metastatic cancers. Immunotherapy-related hepatitis and cholangitis present a diagnostic and management challenge, being rare and incompletely characterised. We aim to report the incidence, features and treatments used for this in a real-world setting and to identify useful biomarkers, which can be used to predict effective use of steroids.
View Article and Find Full Text PDFDig Dis
March 2020
Department of Gastroenterology, Hepatology and Infectious Diseases, Magdeburg, Germany.
Background: Blue light imaging (BLI) and linked color imaging (LCI) are new imaging modalities for the endoscopic evaluation of mucosal changes within the digestive tract. There is little experience with these modalities in the characterization of chronic gastritis (CG) intestinal metaplasia (IM) and atrophy in the stomach.
Aims And Methods: In a single-center observational pilot study, we correlated endoscopic findings with histology in selected patients.